Pantelmin (Mebendazole)

Mebendazole, the active ingredient in Pantelmin, is a benzimidazole anthelmintic presented as an oral tablet for oral use. It treats common intestinal worm infections such as ascariasis, hookworm, trichuriasis and enterobiasis in children and adults, providing effective parasite clearance across various geographic regions worldwide globally.

GNH USA supplies Pantelmin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. The company adheres to WHO GMP guidelines and provides reliable logistics for cross‑border distribution.

Pantelmin (mebendazole) is used to treat intestinal helminth infections by disrupting parasite metabolism. - Ascariasis: eliminates Ascaris lumbricoides worms and reduces egg shedding. - Hookworm infection: eradicates Necator americanus and Ancylostoma duodenale, relieving anemia. - Trichuriasis: clears Trichuris trichiura infestations and improves gastrointestinal symptoms. - Enterobiasis: removes Enterobius vermicularis (pinworm) and prevents reinfestation.

Mebendazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Abdominal pain: mild to moderate discomfort in the stomach area. - Nausea: feeling of queasiness, sometimes leading to vomiting. - Diarrhoea: loose or watery stools. - Headache: mild to moderate head pain. - Dizziness: transient sense of light‑headedness. - Rash: mild skin irritation or itching.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or jaundice. - Severe allergic reaction: anaphylaxis, swelling of face or throat. - Neutropenia: marked reduction in white blood cells. - Stevens‑Johnson syndrome: severe skin blistering. - Bone marrow suppression: pancytopenia in rare cases. - Hepatic failure: rare but potentially life‑threatening liver dysfunction.

Before using Pantelmin, consider the following safety measures. - Pregnancy: unknown safety profile; avoid unless benefits outweigh risks. - Breastfeeding: assess risk; drug may be excreted in milk. - Liver disease: use with caution; monitor hepatic function. - Children: dosage must be determined by a qualified health professional. - Hypersensitivity: discontinue if allergic reactions develop. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and light.

Mebendazole may interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - Cimetidine: may increase mebendazole plasma levels, risking toxicity. - Carbamazepine: induces metabolism, reducing efficacy. - Dexamethasone: may lower drug concentration, compromising treatment. - Antiretrovirals (e.g., ritonavir): can alter mebendazole metabolism. - Warfarin: potential enhancement of anticoagulant effect.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce hormonal efficacy, consider backup contraception. - Other anthelmintics: concurrent use can increase adverse‑event risk. - Antacids: may affect absorption; separate administration by at least 2 hours.